Canada Pension Plan Investment Board
EWTX icon

Canada Pension Plan Investment Board’s Edgewise Therapeutics EWTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,900
Closed -$96.8K – 1800
2025
Q4 		$96.8K Sell
3,900
-600
-13% -$12K ﹤0.01% 1816
2025
Q3 		$73K Buy
4,500
+1,100
+32% +$15.6K ﹤0.01% 1223
2025
Q2 		$44.6K Buy
+3,400
New +$49K ﹤0.01% 1265

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Canada Pension Plan Investment Board's EWTX Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 3,900 shares — an estimated $96.8K sold.

Canada Pension Plan Investment Board first reported a position in EWTX in Q2 2025 and held it in 3 quarters. The position peaked at $96.8K in Q4 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 3,900 Edgewise Therapeutics shares in Q1 2026, an estimated $96.8K.
  • Canada Pension Plan Investment Board first reported a position in Edgewise Therapeutics in Q2 2025 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Edgewise Therapeutics position peaked at $96.8K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.